Brivaracetam
| Material: | 1 ml serum |
| Methods: | Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie |
| Indication | Therapeutic drug monitoring |
| Therapeutic range | 0,2 – 2,0 mg/l |
| Please note | Brivaracetam is an antiepileptic drug, which binds to the synaptic vesicle protein SV2A (similar to Levetiracetam, which is similar in structure), and which causes a regulating effect when releasing stimulating neurotransmitters. Headaches, tiredness and vertigo are potential side effects. |
| Accredited | ja |
More Results for the letter B
- Babesiosis (BABE)
- Babesia
- Bacillus anthracis (BACIL A)
- Anthrax
- Balantidium coli (BALAN CO)
- Intestinal parasites
- Barbiturates (BARB)
- Bartonella henselae (KKKH)
- previously Rochalimaea henselae
- Bartonella quintana (KKKQ)
- previously Rochalimaea quintana
- BCR-ABL fusion gene (PHIL)
- Philadelphia translocation/ t9 / 22
- Bence-Jones proteins in the urine (BENCE)
- Benperidol (BENP)
- Benzene/Benzol (BENZOL)
- Benzodiazepines, Benzodiazepine differentiation (BENZ)
- Beryllium (BERYL)
- Be
- Bile acids in the serum (GALL)
- Bile acids in the stool (GALLS)
- Bile duct epithelium autoantibodies (GALEP)
- Bilharziasis (SCHIS)
- Schistosomiasis
- Biliary canaliculi, autoantibodies to (BILI02)
- Biliary epithelial cells of the small bile ducts, autoantibodies to (BILI03)
- Biliary pigments (BILI01)
- Bilirubin in the serum, direct (BILD)
- conjugated
- Bilirubin in the serum, indirect (BIIN)
- non-conjugated bilirubin
- Bilirubin in the serum, total (BILI)
- Biotin (VITH)
- Vitamin H
- Biotinidase (BIOTIN)
- Bivaracetam (BIVA)
- Blastocystis hominis (BLASTO)
- intestinal parasites
- Blastomycosis (BLAS)
- Blastomyces dermatitidis
- Bleeding time (Bleet)
- Blood count (KBB)
- Blood culture (BLUTKUL)